Beijing Sun Novo Pharmaceutical Research Co Ltd Total Assets

Latest as of March 2026: CN¥2.30 Billion CNY ≈ $336.59 Million USD

Beijing Sun Novo Pharmaceutical Research Co Ltd total assets. Based on the latest financial reports, Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) holds total assets worth CN¥2.30 Billion CNY (≈ $336.59 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Beijing Sun Novo Pharmaceutical Research (688621) total market value for the company's overall valuation and market capitalisation.

Total Assets of Beijing Sun Novo Pharmaceutical Research Co Ltd (2017–2025)

Total assets of Beijing Sun Novo Pharmaceutical Research Co Ltd from 2017 to 2025. This chart illustrates how Beijing Sun Novo Pharmaceutical Research Co Ltd's total assets have evolved over time, based on quarterly financial data. See 688621 live share price for real-time trading data and today's change.

Beijing Sun Novo Pharmaceutical Research Co Ltd - Asset Composition Analysis

Beijing Sun Novo Pharmaceutical Research Co Ltd Total Assets Breakdown (December 2025)

Beijing Sun Novo Pharmaceutical Research Co Ltd total assets breakdown as of December 2025. Beijing Sun Novo Pharmaceutical Research Co Ltd's total assets of CN¥2.30 Billion consist of 76.2% current assets and 23.8% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	20.2%
Accounts Receivable	CN¥581.78 Million	25.5%
Inventory	CN¥14.03 Million	0.6%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥4.73 Million	0.2%
Goodwill	CN¥20.51 Million	0.9%

Asset Composition Trend (2017–2025)

This chart illustrates how Beijing Sun Novo Pharmaceutical Research Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Beijing Sun Novo Pharmaceutical Research short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Beijing Sun Novo Pharmaceutical Research Co Ltd's current assets represent 76.2% of total assets in 2025, an increase from 59.8% in 2017.
Cash Position: Cash and equivalents constituted 20.2% of total assets in 2025, up from 5.1% in 2017.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2017.
Asset Diversification: The largest asset category is accounts receivable at 25.5% of total assets.

Beijing Sun Novo Pharmaceutical Research Co Ltd Competitors by Total Assets

Key competitors of Beijing Sun Novo Pharmaceutical Research Co Ltd based on total assets are shown below.

Company	Country	Total Assets
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
Emcure Pharmaceuticals Ltd NSE:EMCURE	India	Rs96.12 Billion
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥13.98 Billion
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	China	CN¥9.94 Billion
Ajanta Pharma Limited NSE:AJANTPHARM	India	Rs56.72 Billion
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	China	CN¥4.49 Billion
Luoxin Pharmaceuticals Group Stock Co Ltd SHE:002793	China	CN¥3.61 Billion

Beijing Sun Novo Pharmaceutical Research Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.79	1.64	3.65
Quick Ratio	1.77	1.62	3.62
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥758.31 Million	CN¥643.92 Million	CN¥580.88 Million

Beijing Sun Novo Pharmaceutical Research Co Ltd - Advanced Valuation Insights

This section examines the relationship between Beijing Sun Novo Pharmaceutical Research Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	5.70
Latest Market Cap to Assets Ratio	0.38
Asset Growth Rate (YoY)	15.0%
Total Assets	CN¥2.28 Billion
Market Capitalization	$872.56 Million USD

Valuation Analysis

Below Book Valuation: The market values Beijing Sun Novo Pharmaceutical Research Co Ltd's assets below their book value (0.38x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Beijing Sun Novo Pharmaceutical Research Co Ltd's assets grew by 15.0% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Beijing Sun Novo Pharmaceutical Research Co Ltd (2017–2025)

The table below shows the annual total assets of Beijing Sun Novo Pharmaceutical Research Co Ltd from 2017 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥2.28 Billion ≈ $334.34 Million	+14.97%
2024-12-31	CN¥1.99 Billion ≈ $290.81 Million	+6.67%
2023-12-31	CN¥1.86 Billion ≈ $272.62 Million	+27.33%
2022-12-31	CN¥1.46 Billion ≈ $214.10 Million	+17.74%
2021-12-31	CN¥1.24 Billion ≈ $181.84 Million	+222.89%
2020-12-31	CN¥384.86 Million ≈ $56.32 Million	+34.79%
2019-12-31	CN¥285.51 Million ≈ $41.78 Million	+41.70%
2018-12-31	CN¥201.50 Million ≈ $29.49 Million	+83.06%
2017-12-31	CN¥110.07 Million ≈ $16.11 Million	--

About Beijing Sun Novo Pharmaceutical Research Co Ltd

SHG:688621 China Drug Manufacturers - Specialty & Generic

Market Cap

$872.56 Million

CN¥5.96 Billion CNY

Market Cap Rank

#9180 Global

#2243 in China

Share Price

CN¥53.24

Change (1 day)

-4.04%

52-Week Range

CN¥47.96 - CN¥78.30

All Time High

CN¥128.22